
Lincoln Pharma Q2 FY27: PAT up 2% YoY as margins compress, revenue +17%
pharmaceuticals · margin compression · profit growth lag
BSE: 531633
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)
Corporate Events
Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗Board Meeting
The 32nd Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
considering and approving un-audited financial results, any …
BSE Filing ↗Board Meeting
considering and approving unaudited financial results, any o…
BSE Filing ↗Board Meeting
Consider and approve the audited (standalone and consolidate…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results
BSE Filing ↗Board Meeting
Consider and approve un-audited financial results (standalon…
BSE Filing ↗Board Meeting
Consider and approve Audited (standalone and consolidated) f…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗Board Meeting
To consider and approve un-audited financial results (standa…
BSE Filing ↗